Puma Biotechnology Total Assets Over Time
| PBYI Stock | USD 6.27 -0.06 -0.95% |
Fundamental trends for Puma Biotechnology compare profitability, leverage, and valuation drift. Persistent trend patterns in Puma Biotechnology's ratios help distinguish signal from noise.
Use Puma Biotechnology Performance alongside Puma Biotechnology Correlation to build context for Puma Biotechnology. Quarterly Earnings Growth -0.34 | Earnings Share 0.61 | Revenue Per Share | Quarterly Revenue Growth 0.277 | Return On Assets |
The market value of Puma Biotechnology is measured differently than book value, which reflects Puma accounting equity. This view summarizes available data without implying outcomes.
The concept of value for Puma Biotechnology differs from its quoted price, since each reflects a different lens. This information is provided for contextual purposes.
Peer Comparison: Total Assets
Total assets refers to the total amount of Puma Biotechnology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Puma Biotechnology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Compare Puma Biotechnology and related stocks such as Eledon Pharmaceuticals, Abeona Therapeutics, and Voyager Therapeutics Total Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELDN | 12 M | 12 M | 12 M | 32.3 M | 107.7 M | 68 M | 29.8 M | 20.9 M | 17 M | 10.9 M | 197.2 M | 170.5 M | 92.8 M | 125.9 M | 177.4 M | 237.6 M | 249.5 M |
| ABEO | 2.1 M | 3.8 M | 1.7 M | 613 K | 16.6 M | 80.1 M | 111.1 M | 178.8 M | 174.4 M | 223.4 M | 151.2 M | 79.6 M | 64.2 M | 64 M | 108.9 M | 219.6 M | 230.5 M |
| VYGR | 149 K | 149 K | 149 K | 149 K | 11.5 M | 229.5 M | 189.6 M | 184.5 M | 177 M | 354.8 M | 261.6 M | 193.9 M | 159.4 M | 351.3 M | 393.1 M | 252.3 M | 233.4 M |
| AVIR | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 22.1 M | 863.6 M | 772.9 M | 666.7 M | 595 M | 464.7 M | 315.2 M | 513.6 M |
| ARCT | 1.2 M | 1.2 M | 201 K | 50.3 M | 22.3 M | 71.7 M | 51.6 M | 52 M | 44.2 M | 82.1 M | 476.5 M | 392.8 M | 450.4 M | 429.4 M | 344.1 M | 271.1 M | 200.9 M |
| ALLO | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 773.9 M | 717.8 M | 1.2 B | 1.1 B | 821.6 M | 642.8 M | 548.7 M | 415.9 M | 757.7 M |
| HUMA | 168.7 M | 168.7 M | 168.7 M | 168.7 M | 168.7 M | 168.7 M | 168.7 M | 168.7 M | 168.7 M | 168.7 M | 106.7 M | 286.5 M | 204.3 M | 128.2 M | 137.9 M | 124.1 M | 137.6 M |
| TRDA | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 43.5 M | 305.8 M | 252.1 M | 469.2 M | 526.3 M | 377.4 M | 313.1 M |
| SGMT | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 69 M | 59 M | 33 M | 96.7 M | 160.3 M | 116.5 M | 85.7 M |
My Equities
My Current Equities and Potential Positions
| Puma Biotechnology | PBYI |
| Classification | Biotech |
| Business Address | 10880 Wilshire Boulevard, |
| Exchange | NASDAQ Exchange |
USD 6.27